离岸价格
Get Latest Price0.2 ~ 0.3 / Box ( Negotiable )
|10000 Box Minimum Order
国:
China
モデル番号:
-
离岸价格:
0.2 ~ 0.3 / Box ( Negotiable )Get Latest Price
ロケーション:
-
最低注文量の価格:
0.2 per Box
最低注文量:
10000 Box
パッケージの詳細:
cartons
納期:
40days
供給能力:
100000 Box per Day
支払いタイプ:
L/C, T/T
製品グループ :
連絡先担当者 Mr. Kevin
No. 35 Huitong Road, Shijiazhuang, China, Shijiazhuang, Hebei
Product Name: Dextrose Injection 5% ,Glucose Injection 5%,Dextrose infusion 5%,Glucose infusion 5%
Product Description :A clear, colourless or almost colourless liquid,taste sweet.
Strength:5g/**0ml,*2.5g/**0ml,*5g/**0ml
INN or Generic Name:Hydrous Dextrose
Pharmaceutical Dosage
Form: injection
Port:Any port (depends on
requests)
Certificate:GMP
Exporting Region:Areas which GMP is applicable
Therapeutic indications
Intravenous solutions containing Dextrose are indicated for
parenteral replenishment of fluid and minimal carbohydrate calories
as required by the clinical condition of the patient.
Posology and method of administration
The dose is dependent upon the age, weight and clinical condition of the patient.
As reported in the literature, the dosage and constant infusion rate of intravenous Dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.
Drug Interactions
Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.
Contraindications:
5% Dextrose Injection, USP without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.
Special warning and precautions for use:
Warnings
Excessive administration of potassium-free solutions may result in
significant hypokalemia.
The intravenous administration of these solutions can cause fluid
and/or solute overloading resulting in dilution of serum
electrolyte concentrations, overhydration, congested states or
pulmonary edema.
The risk of dilutional states is inversely proportional to the
electrolyte concentrations of administered parenteral solutions.
The risk of solute overload causing congested states with
peripheral and pulmonary edema is directly proportional to the
electrolyte concentrations of such solutions.
Precautions
Clinical evaluation and periodic laboratory determinations are
necessary to monitor changes in fluid balance, electrolyte
concentrations and acid-base balance during prolonged parenteral
therapy or whenever the condition of the patient warrants such
evaluation.
Solutions containing Dextrose should be used with caution in
patients with known subclinical or overt diabetes mellitus.
Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Carcinogenesis, Mutagenesis, Impairment of
Fertility:
Studies with 5% Dextrose Injection, USP have not been performed to
evaluate carcinogenic potential, mutagenic potential or effects on
fertility.
Interaction with other medicinal products and other forms of Interactions
None known
Pregnancy and lactation
Pregnancy:
Teratogenic effects
Pregnancy Category C. Animal reproduction studies have not been
conducted with Dextrose. It is also not known whether Dextrose can
cause fetal harm when administered to a pregnant woman or can
affect reproduction capacity. Dextrose should be given to a
pregnant woman only if clearly needed.
Nursing Mothers:
Caution should be exercised when 5% Dextrose Injection, USP is
administered to a nursing mother.
Pediatric Use:
The safety and effectiveness in the pediatric population are based
on the similarity of the clinical conditions of the pediatric and
adult populations. In neonates or very small infants the volume of
fluid may affect fluid and electrolyte balance.
Frequent monitoring of serum glucose concentrations is required
when Dextrose is prescribed to pediatric patients, particularly
neonates and low birth weight infants.
In very low birth weight infants, excessive or rapid administration
of Dextrose injection may result in increased serum osmolarity and
possible intracerebral hemorrhage.
Geriatric Use:
An evaluation of current literature revealed no clinical experience
identifying differences in response between elderly and younger
patients. In general, dose selection for an elderly patient should
be cautious, usually starting at the low end of the dosing range,
reflecting the greater frequency of decreased hepatic, renal, or
cardiac function, and of concomitant disease or other drug
therapy..
Effects on ability to drive and use machine
Not applicable.
Undesirable effects
Reactions which may occur because of the solution or the technique
of administration include febrile response, infection at the site
of injection, venous thrombosis or phlebitis extending from the
site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion,
evaluate the patient, institute appropriate therapeutic
countermeasures and save the remainder of the fluid for examination
if deemed necessary.
Overdose and special antidotes
In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS.
国: | China |
モデル番号: | - |
离岸价格: | 0.2 ~ 0.3 / Box ( Negotiable ) Get Latest Price |
ロケーション: | - |
最低注文量の価格: | 0.2 per Box |
最低注文量: | 10000 Box |
パッケージの詳細: | cartons |
納期: | 40days |
供給能力: | 100000 Box per Day |
支払いタイプ: | L/C, T/T |
製品グループ : | generic |